139 related articles for article (PubMed ID: 8724669)
21. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus.
Jacques D; Dumont Y; Fournier A; Quirion R
Neuroscience; 1997 Jul; 79(1):129-48. PubMed ID: 9178870
[TBL] [Abstract][Full Text] [Related]
22. Differential distribution of neuropeptide Y Y1 and Y2 receptors in rat and guinea-pig brains.
Gehlert DR; Gackenheimer SL
Neuroscience; 1997 Jan; 76(1):215-24. PubMed ID: 8971773
[TBL] [Abstract][Full Text] [Related]
23. Preferential expression of the neuropeptide Y Y1 over the Y2 receptor subtype in cultured hippocampal neurons and cloning of the rat Y2 receptor.
St-Pierre JA; Dumont Y; Nouel D; Herzog H; Hamel E; Quirion R
Br J Pharmacol; 1998 Jan; 123(2):183-94. PubMed ID: 9489605
[TBL] [Abstract][Full Text] [Related]
24. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Chen SH; Cheung RT
Neuroscience; 2003; 116(1):119-26. PubMed ID: 12535945
[TBL] [Abstract][Full Text] [Related]
25. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Kask A; Rägo L; Harro J
Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
[TBL] [Abstract][Full Text] [Related]
26. Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.
Tough IR; Cox HM
Eur J Pharmacol; 1996 Aug; 310(1):55-60. PubMed ID: 8880067
[TBL] [Abstract][Full Text] [Related]
27. Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain.
Dumont Y; Fournier A; St-Pierre S; Quirion R
J Neurosci; 1993 Jan; 13(1):73-86. PubMed ID: 8423484
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
29. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem.
Ny L; Grundemar L
Neurosci Lett; 1997 Jan; 221(2-3):113-6. PubMed ID: 9121677
[TBL] [Abstract][Full Text] [Related]
32. Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.
Vanderheyden PM; Van Liefde I; De Backer JP; Vauquelin G
Eur J Pharmacol; 1997 Jul; 331(2-3):275-84. PubMed ID: 9274990
[TBL] [Abstract][Full Text] [Related]
33. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
Abounader R; Villemure JG; Hamel E
Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
[TBL] [Abstract][Full Text] [Related]
34. Quantitative autoradiographic distribution of [125I]Bolton-Hunter neuropeptide Y receptor binding sites in rat brain. Comparison with [125I]peptide YY receptor sites.
Martel JC; Fournier A; St Pierre S; Quirion R
Neuroscience; 1990; 36(1):255-83. PubMed ID: 2170863
[TBL] [Abstract][Full Text] [Related]
35. Association of neuropeptide Y Y1 receptors with glutamate-positive and NPY-positive neurons in rat hippocampal cultures.
St-Pierre JA; Nouel D; Dumont Y; Beaudet A; Quirion R
Eur J Neurosci; 2000 Apr; 12(4):1319-30. PubMed ID: 10762361
[TBL] [Abstract][Full Text] [Related]
36. [Leu31, Pro34]neuropeptide Y: a specific Y1 receptor agonist.
Fuhlendorff J; Gether U; Aakerlund L; Langeland-Johansen N; Thøgersen H; Melberg SG; Olsen UB; Thastrup O; Schwartz TW
Proc Natl Acad Sci U S A; 1990 Jan; 87(1):182-6. PubMed ID: 2153286
[TBL] [Abstract][Full Text] [Related]
37. Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Madsen TM; Greisen MH; Nielsen SM; Bolwig TG; Mikkelsen JD
Neuroscience; 2000; 98(1):33-9. PubMed ID: 10858609
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of (125)I-1229U91 binding to Y1 and Y4 neuropeptide Y/Peptide YY receptors.
Schober DA; Gackenheimer SL; Heiman ML; Gehlert DR
J Pharmacol Exp Ther; 2000 Apr; 293(1):275-80. PubMed ID: 10734179
[TBL] [Abstract][Full Text] [Related]
39. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
40. Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization.
Allen CJ; Ghilardi JR; Vigna SR; Mannon PJ; Taylor IL; McVey DC; Maggio JE; Mantyh PW
Neuroscience; 1993 Apr; 53(3):889-98. PubMed ID: 7683778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
